Share Price | Innovex International, Inc. Stock Analysis & Recommendation

Q: Is Innovex International, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Innovex International, Inc. has moved from very attractive to attractive, indicating a shift in perception. The company appears to be undervalued with a P/E ratio of 11.90, which is favorable compared to the industry average, and an EV/EBITDA of 7.11, suggesting a solid valuation relative to earnings before interest, taxes, depreciation, and amortization. Additionally, the absence of a PEG ratio and dividend yield highlights a focus on growth rather than income generation.In comparison to its peers, Innovex International is positioned well, with a lower P/E ratio than many competitors in the oil industry. For instance, if we consider a peer with a higher P/E, it reinforces the attractiveness of Innovex's valuation. Despite recent challenges reflected in its long-term returns, the stock has outperformed the S&P 500 over the past year, returning 12.86% compared to the S&P 500's 14.08%. This performance, alongside its attractive valuation metrics, supports the conclusion that Innovex International, Inc. is currently undervalued.

Q: Is Innovex International, Inc. technically bullish or bearish?

As of 1 October 2023, the technical stance for Innovex International, Inc. is mildly bullish. Key indicators driving this stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and a bullish daily moving average. However, the Dow Theory indicates a mildly bullish weekly trend but a bearish monthly trend, and the On-Balance Volume shows a mildly bearish weekly signal. In terms of performance, Innovex has outperformed the S&P 500 over the past week and month, with returns of 2.32% and 4.87% compared to the S&P's 1.05% and 2.33%, respectively. However, over longer periods, such as the 1Y and 3Y, the stock has underperformed the benchmark.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

97.94 k

Shareholding (Mar 2026)

FII

5.03%

Held by 83 FIIs

DII

94.98%

Held by 39 DIIs

Promoter

0.00%

Is Innovex International, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Innovex International, Inc. is considered undervalued with a favorable P/E ratio of 11.90 and an EV/EBITDA of 7.11, despite recent challenges, as it has outperformed the S&P 500 over the past year.

View full answer

Is Innovex International, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, Innovex International, Inc. has a mildly bullish technical stance, supported by positive indicators like a bullish MACD and Bollinger Bands, although it shows mixed trends with a bearish monthly outlook and has underperformed the S&P 500 over the long term despite recent short-term gains.

View full answer

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 197.14 MM
NET SALES(HY) At USD 464.65 MM has Grown at 79.89%
ROCE(HY) Highest at 15.64%

With ROE of 0.00%, it has a valuation with a 0.00 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Oil

Market cap

USD 1,737 Million (Small Cap)

P/E

18.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.17

Return on Equity

-999,999.00%

Price to Book

1.64

Revenue and Profits:

Net Sales:

239 Million

(Quarterly Results - Mar 2026)

Net Profit:

-17 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

22.05%

6 Months

30.77%

1 Year

75.72%

2 Years

59.19%

3 Years

20.11%

4 Years

0.48%

5 Years

-21.99%

Innovex International, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

21.80%

EBIT Growth (5y)

56.40%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

72.23%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.64

EV to EBIT

13.66

EV to EBITDA

8.22

EV to Capital Employed

1.78

EV to Sales

1.59

PEG Ratio

Dividend Yield

ROCE (Latest)

13.02%

ROE (Latest)

9.38%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 70 Schemes (32.77%)

Foreign Institutions

Held by 83 Foreign Institutions (5.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -12.65% vs 14.00% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -219.29% vs -64.29% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "239.00",
          "val2": "273.60",
          "chgp": "-12.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.00",
          "val2": "50.40",
          "chgp": "-8.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-50.40",
          "val2": "-4.50",
          "chgp": "-1,020.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.70",
          "val2": "14.00",
          "chgp": "-219.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "111.00%",
          "val2": "115.60%",
          "chgp": "-0.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 48.05% vs 18.96% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -40.63% vs 89.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "978.30",
          "val2": "660.80",
          "chgp": "48.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "187.00",
          "val2": "124.80",
          "chgp": "49.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "2.40",
          "chgp": "8.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.30",
          "val2": "49.00",
          "chgp": "-149.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "83.30",
          "val2": "140.30",
          "chgp": "-40.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "116.30%",
          "val2": "129.00%",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]